Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.200
-0.040 (-1.79%)
Dec 16, 2025, 4:00 PM EST - Market closed

Traws Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
183216145386
Upgrade
Market Cap Growth
22.54%106.05%15.90%-74.63%-38.16%123.22%
Upgrade
Enterprise Value
1127-10-29-662
Upgrade
Last Close Price
2.208.8818.6416.1463.75174.67
Upgrade
PS Ratio
5.15142.7869.2959.79235.71372.94
Upgrade
PB Ratio
3.45-1.021.470.481.1613.95
Upgrade
P/TBV Ratio
8.91-1.470.481.1613.95
Upgrade
EV/Sales Ratio
3.92118.84---268.19
Upgrade
Asset Turnover
0.270.010.010.010.010.01
Upgrade
Quick Ratio
1.072.002.264.829.011.90
Upgrade
Current Ratio
1.222.162.464.899.071.97
Upgrade
Return on Equity (ROE)
-1059.63%--97.22%-50.96%-61.81%-283.48%
Upgrade
Return on Assets (ROA)
-92.29%-65.35%-40.89%-25.87%-27.32%-71.56%
Upgrade
Return on Capital (ROIC)
-785.48%--65.09%-32.96%-39.43%-176.02%
Upgrade
Return on Capital Employed (ROCE)
-346.50%-185.50%-150.80%-62.70%-33.40%-250.80%
Upgrade
Earnings Yield
-52.08%-516.07%-121.00%-140.35%-30.34%-29.20%
Upgrade
FCF Yield
-110.73%-92.33%-114.60%-120.59%-36.58%-26.80%
Upgrade
Buyback Yield / Dilution
-570.57%-84.94%-0.39%-24.22%-45.07%-1109.88%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q